Avanos Medical AVNS Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Avanos Medical (AVNS) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 1.2M in Q1 2026.
- How has Avanos Medical's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- Avanos Medical's stock options excluded as their inclusion would be anti-dilutive (in shares) decreased by 20.0% year-over-year, from 1.5M to 1.2M.
- What is the long-term trend for Avanos Medical's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Over 4 years (2021 to 2025), Avanos Medical's stock options excluded as their inclusion would be anti-dilutive (in shares) has grown at a 15.1% compound annual growth rate (CAGR), from 5.3M to 9.3M.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- Represents the number of equity-based instruments, such as stock options or restricted stock units, that are excluded from the diluted earnings per share calculation because their exercise price exceeds the average market price of the company's common stock. These securities are considered antidilutive because their inclusion would increase earnings per share or decrease the loss per share. Monitoring this figure helps investors understand the potential future dilution impact if market conditions change.